Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillance-Reference-Cited by-同舟云学术

Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillance

Published:2020-10 Issue: Volume:64 Page:101950
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Asano Koichiro,Sumi Kazuya,Yoshisue Hajime,Nakamura Noriko,Nagasaki Makoto,Sasajima Takayoshi,Matsumoto Hisako

Funder

Novartis Pharma

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference36 articles.

1. Japanese guidelines for adult asthma 2017;Ichinose;Allergol. Int.,2017

2. A retrospective cohort study evaluating healthcare resource utilization in patients with asthma in Japan;Inoue;NPJ Prim Care Respir Med,2019

3. Interim analysis of post-marketing surveillance of omalizumab in Japan;Ohta;Eur. Respir. J.,2013

4. Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma;Odajima;Allergol. Int.,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of clinical biomarkers in predicting the effectiveness of omalizumab;Therapeutic Advances in Respiratory Disease;2023-01

2. Asthma in an aging world;Asthma in the 21st Century;2023

3. Clinical Application of Omazumab in the Treatment of Moderate and Severe Allergic Asthma;Advances in Clinical Medicine;2023

4. Response to Omalizumab as an Add-On Therapy in the Treatment of Allergic Asthma in Adult Chinese Patients—A Retrospective Study;Vaccines;2022-12-02

5. Response to budesonide formoterol and omalizumab combination therapy: a retrospective study in adults with allergic asthma;2022-10-06